Validation of an oxygen-dependent tumour response simulation model in three sublines of a rat prostate carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2022
- Schlagwort
-
Radiotherapy
Cancer
Radiobiology
Prostate
Medical physics
Radiotherapy
Radiobiology
Medical physics
Computer model
Prostate cancer
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.11588/heidok.00031668
- URN
-
urn:nbn:de:bsz:16-heidok-316685
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:34 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Paredes-Cisneros, Isabela
- Karger, Christian
- Universitätsbibliothek Heidelberg
Entstanden
- 2022
Ähnliche Objekte (12)
HLA-dependent tumour development: a role for tumour associate macrophages?
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
Latitude-dependent oxygen fugacity in arc magmas
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: a Theranostic for Acute Stroke
Identification of genes that promote PI3K pathway activation and prostate tumour formation
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking
Method validation of circulating tumour cell enumeration at low cell counts
HLA-dependent tumour development: a role for tumour associate macrophages?
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
Latitude-dependent oxygen fugacity in arc magmas
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: a Theranostic for Acute Stroke
Identification of genes that promote PI3K pathway activation and prostate tumour formation
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking
Method validation of circulating tumour cell enumeration at low cell counts
HLA-dependent tumour development: a role for tumour associate macrophages?
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
Latitude-dependent oxygen fugacity in arc magmas
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: a Theranostic for Acute Stroke
Identification of genes that promote PI3K pathway activation and prostate tumour formation
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking